Looking to publish in NAR Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowNAR Cancer is a fully open access journal publishing original research and review articles at the intersection of the nucleic acids and cancer fields. The journal emphasizes rapid publication, a transparent and fair editorial process, and Open Science.
Looking to publish in NAR Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
NAR Cancer accepts the following article types. Click on an article type to view submission instructions.
Standard Articles
Review Articles
Critical Reviews
Short Reviews
Cancer Data Resource Articles
Critical Reviews And Perspectives
Cancer Computational Biology
Cancer Genomics
Dna Damage, Sensing And Repair
Cancer Gene Regulation, Chromatin And Epigenetics
Cancer-Specific Rnas And Rna Processing
Nucleic Acid-Based Cancer Therapeutics
Cancer Data Resources
Recent Publications
MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription
Reshma Kalyan Sundaram, Kshitiz Parihar, Stephanie Monson, Ravi Radhakrishnan, Bomyi Lim
Efficient gene disruption with CRISPR–Cas3 in human T cells
Tomoaki Fujii, Yukimi Sakoda, Kazuto Yoshimi, Kohei Takeshita, Shoji Watanabe, Ryuya Iida, Tsubasa Obo, Kazumasa Yokoyama, Koji Tamada, Tomoji Mashimo
Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing
Berenice Cuevas-Estrada, Juan A Ríos-Rodríguez, José A García-Pacheco, Talia Wegman-Ostrosky, Alejandra Cervera, Nicolas Alcaraz, Michel Montalvo-Casimiro, Alejandra Barrón-Hernández, Clementina Castro-Hernández, Miguel A Jiménez-Ríos, Nora Sobrevilla-Moreno, Cristian Arriaga-Canon, Luis A Herrera, Rodrigo González-Barrios
Sensitive detection of somatic mutations in GC-rich cancer gene promoters
Meifang Qi, Preshita Sanjay Dave, Nicole Francis, Matthew DeFelice, Sam Pollock, Holly Corbitt, Irene Rin Mitsiades, Gengchao Wang, Paul Frere, Alan Fox, Gregory Khitrov, Caroline Petersen, Katie Larkin, Susanna Hamilton, Leif W Ellisen, Doga C Gulhan, Alfredo Hidalgo-Miranda, Niall Lennon, Carrie Cibulskis, Esther Rheinbay
Disruption of the structural maintenance of chromosomes 5/6 complex enables tumor mutagenesis
Thi Tran, Jiayi Fan, Xiaolan Zhao, Abby M Green
Frequently asked questions
How long does it take to publish?
Papers are published in the currently open issue after copyediting and review of the final proof. Authors are encouraged to submit revisions within 30–60 days, extensions up to six months may be requested, and proofs should be corrected within 48 hours.
Reformat to NAR Cancer using Livewrite PremiumIs a cover letter required?
A cover letter should be uploaded at submission. It should briefly list the main conclusions, explain the significance of the work, disclose previous submissions, related manuscripts under consideration elsewhere, and any personal communications or AI use as required. Cover letters are required for resubmissions and may be used to request exclusion of specific reviewers.
Reformat to NAR Cancer using Livewrite PremiumWhat are the publication costs?
Articles in hybrid journals may be published open access upon payment of an Article Processing Charge (APC). An example open access charge shown is 3625 USD for a book review. Corresponding authors in Low and Middle Income countries and regions may receive a waiver or discount of the APC.
Reformat to NAR Cancer using Livewrite Premium